11-13 November 2025
Congress Center BaselBasel, SwitzerlandDr. Tsubasa Aoki, PhDResearcher at Ajinomoto Co.Speaker
Profile
Dr. Tsubasa Aoki has been dedicated to antibody engineering, aiming to develop novel drug modalities as a researcher at Ajinomoto Co., Inc. His work includes the development of antibody-oligonucleotide conjugates and antibody-protein conjugates by using our proprietary conjugation technology, AJICAP®. Dr. Aoki earned his Ph.D. in Engineering from the University of Tokyo, Japan, in 2023. His doctoral research focused on chiroptical properties of the self-assembly systems.
Agenda Sessions
Accelerating the Development of Antibody-Oligonucleotide Conjugates (AOCs) by AJICAP® Site-Specific Chemical Conjugation Technology
, 13:25View Session